Transplantation procedure
| Donor | |
| HLA-identical family donor | 48 |
| Matched unrelated donor | 52 |
| Donor sex, M/F* | 50/46 |
| Median donor age, y† (range) | 19 (1-54) |
| Donor HCMV serology | |
| Negative | 55 |
| Positive | 38 |
| Unknown | 7 |
| Stem cell source | |
| Bone marrow | 79 |
| Peripheral blood | 14 |
| Cord blood | 7 |
| Median mononuclear cell dose infused | |
| Bone marrow, × 108/kg (range) | 6.1 (0.6-18.9) |
| Peripheral blood, CD34+ × 106/kg (range) | 20 (10-30) |
| Cord blood, × 107/kg (range) | 5 (4-14) |
| GVHD prophylaxis: matched family donor; matched unrelated donor | |
| None | 1; 0 |
| Cs-A | 32; 0 |
| MTX | 2; 0 |
| Cs-A + MTX | 7; 3 |
| Cs-A + ALG or MoAbs | 3; 3 |
| Cs-A + MTX + ALG or MoAbs | 1; 41 |
| Cs-A ± PDN ± MTX ± MoAbs | 2; 5 |
| Donor | |
| HLA-identical family donor | 48 |
| Matched unrelated donor | 52 |
| Donor sex, M/F* | 50/46 |
| Median donor age, y† (range) | 19 (1-54) |
| Donor HCMV serology | |
| Negative | 55 |
| Positive | 38 |
| Unknown | 7 |
| Stem cell source | |
| Bone marrow | 79 |
| Peripheral blood | 14 |
| Cord blood | 7 |
| Median mononuclear cell dose infused | |
| Bone marrow, × 108/kg (range) | 6.1 (0.6-18.9) |
| Peripheral blood, CD34+ × 106/kg (range) | 20 (10-30) |
| Cord blood, × 107/kg (range) | 5 (4-14) |
| GVHD prophylaxis: matched family donor; matched unrelated donor | |
| None | 1; 0 |
| Cs-A | 32; 0 |
| MTX | 2; 0 |
| Cs-A + MTX | 7; 3 |
| Cs-A + ALG or MoAbs | 3; 3 |
| Cs-A + MTX + ALG or MoAbs | 1; 41 |
| Cs-A ± PDN ± MTX ± MoAbs | 2; 5 |
Cl-A indicates cyclosporin-A; MTX, short-term methotrexate; ALG, antilymphocyte globulin; MoAbs, monoclonal antibodies.
*Four unknown; †21 unknown.